| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/14/2013 | CN102688202B Temozolomide freeze-dried preparation |
| 08/14/2013 | CN102670859B Topical traditional Chinese medicinal composition for preventing and treating sarcomas |
| 08/14/2013 | CN102670512B Sonodynamic liposomal material, preparation method and application thereof in preparing pharmorubicin composite liposomal |
| 08/14/2013 | CN102659840B Imidazole diphosphonie acid compound and pharmaceutically-acceptable salt and medicinal application thereof |
| 08/14/2013 | CN102652830B Application of Cathelicidin-BF (bungarus fasciatus) in preparation of antineoplastic medicament |
| 08/14/2013 | CN102614527B Antiacid nano oral deoxyribonucleic acid (DNA) anti-tumor vaccine with potential of hydrogen (pH) sensitive characteristic and preparation method |
| 08/14/2013 | CN102614284B Oral liquid for treating malignancy and preparing method |
| 08/14/2013 | CN102600148B Composition containing carbazole sulfonamide medicaments and preparation method of composition |
| 08/14/2013 | CN102552934B Adriamycin nano-particles and preparation method thereof |
| 08/14/2013 | CN102552146B Epirubicin liposome as well as preparation method and preserving method thereof |
| 08/14/2013 | CN102488836B Medicine for treating bladder tumor |
| 08/14/2013 | CN102462687B Pharmaceutical composition containing GC-20 |
| 08/14/2013 | CN102432658B Method for synthesizing androstane-17(20)-alkenyl-21-ketone |
| 08/14/2013 | CN102432605B Kinase inhibitor containing methyl-D3 |
| 08/14/2013 | CN102423493B Medicine for eliminating breast cancer cells with high efficiency and high specificity |
| 08/14/2013 | CN102379934B High efficiency liquid chromatography detection method for content of raddeanin A in rhizoma anemones raddeanae |
| 08/14/2013 | CN102285934B Spirocycle dienone derivates as well as preparation method and application thereof |
| 08/14/2013 | CN102268191B Heptamethine indocyanine dye, synthetic method thereof and applications thereof |
| 08/14/2013 | CN102218028B Antisense oligonucleotide injection for treating liver cancer and preparation method thereof |
| 08/14/2013 | CN102174514B Double-stranded siRNA (Small Interfering Ribonucleic Acid) for suppressing Hmga2 gene expression and application thereof |
| 08/14/2013 | CN102173987B New manchurian walnut bark acid and derivatives thereof, and preparation methods and medical application thereof |
| 08/14/2013 | CN102133233B Centipede extract capable of resisting tumor activity and preparation method thereof |
| 08/14/2013 | CN102126983B Colchicin derivative, preparation method and application thereof |
| 08/14/2013 | CN102123988B Squaric acid derivatives as inhibitors of nicotinamide |
| 08/14/2013 | CN102108356B Novel promoter and virus vector containing same |
| 08/14/2013 | CN102060843B Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 08/14/2013 | CN102036710B Magnetic breather pump and method for treating brain tumor using the same |
| 08/14/2013 | CN101993415B Compound as Hedgehog path inhibitor, medicine composition containing same and application thereof |
| 08/14/2013 | CN101983964B Compound with antibacterial activity and antitumor activity and preparation method and applications thereof |
| 08/14/2013 | CN101970500B Anti-tyrp1 antibodies |
| 08/14/2013 | CN101966157B Decitabine sustained release microsphere and preparation method thereof |
| 08/14/2013 | CN101952320B Material with immunogenicity |
| 08/14/2013 | CN101942017B Tumor marker |
| 08/14/2013 | CN101879202B Application of Java brucea fruit oil emulsion injection to anticancer aspect |
| 08/14/2013 | CN101743229B Quinazolinamide derivatives |
| 08/14/2013 | CN101724599B Use of dendrimers to stimulate cell growth |
| 08/14/2013 | CN101695501B Chitosan entrapment body of nano-scale arsenous acid and manufacturing method thereof |
| 08/14/2013 | CN101486682B N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 08/14/2013 | CN101421282B Treatment of hyperproliferative diseases with vinca alkaloidn-oxide and analogs |
| 08/14/2013 | CN101420978B Destruction of tumor cells expressing low to medium levels of tumor associated target antigens by trifunctional bispecific antibodies |
| 08/14/2013 | CN101390867B Compositions and methods for treatment of infection |
| 08/14/2013 | CN101282946B 半胱氨酸蛋白酶抑制剂及它们的治疗应用 Cysteine protease inhibitors and their therapeutic applications |
| 08/14/2013 | CN101068836B Anti-glypican 3 antibody having modified sugar chain |
| 08/13/2013 | US8507748 Method for the production of a single heavy chain antibody |
| 08/13/2013 | US8507710 Use of perifosine in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals |
| 08/13/2013 | US8507676 Heterocyclic oxime compounds |
| 08/13/2013 | US8507672 Substituted pyrrolo[2,3-d]pyrimidines as LIM kinase 2 inhibitors |
| 08/13/2013 | US8507505 Dihydropyrazolopyrimidinone derivative |
| 08/13/2013 | US8507502 Fused bicyclic and tricyclic pyrimidine compounds as tyrosine kinase inhibitors |
| 08/13/2013 | US8507491 Compounds and compositions as hedgehog pathway inhibitors |
| 08/13/2013 | US8507490 Tetrasubstituted pyridazine hedgehog pathway antagonists |
| 08/13/2013 | US8507480 Isoxazole compounds as inhibitors of heat shock proteins |
| 08/13/2013 | US8507475 Substituted heteroarylamide diazepinopyrimidone derivatives |
| 08/13/2013 | US8507464 Phosphoramidate alkylator prodrugs |
| 08/13/2013 | US8507426 Peptides and related molecules that bind to TALL-1 |
| 08/13/2013 | US8507010 Compositions comprising quinazoline derivatives |
| 08/13/2013 | US8506987 Ocular implant made by a double extrusion process |
| 08/13/2013 | CA2768841C Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 08/13/2013 | CA2768828C Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 08/13/2013 | CA2768773C Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 08/13/2013 | CA2743019C Akt and p70 s6 kinase inhibitors |
| 08/13/2013 | CA2634149C Novel hydrogen sulfate salt for use in the treatment of hyperproliferative diseases |
| 08/13/2013 | CA2611892C Tetrahydroquinoline derivatives as motor protein eg5 inhibitors and antitumor agents |
| 08/13/2013 | CA2578052C Methods of activating nkt cells |
| 08/13/2013 | CA2544473C A recombinant protein having an anti-cancer effect, its encoding gene and uses thereof |
| 08/13/2013 | CA2543406C Mutants of human chondromodulin-i (hchm-i) and uses thereof in inhibiting angiogenesis and bone resorption |
| 08/13/2013 | CA2482930C Epha2 antigen t epitopes |
| 08/13/2013 | CA2477236C Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders |
| 08/13/2013 | CA2469151C Immunocytokines with modulated selectivity |
| 08/13/2013 | CA2464121C Pregnancy-associated plasma protein-a2 (papp-a2) |
| 08/13/2013 | CA2438513C Modified anti-egfr antibodies with reduced immunogenicity |
| 08/13/2013 | CA2433316C Molecular antigen array |
| 08/08/2013 | WO2013116821A1 Compositions comprising ndga derivatives and sorafenib and their use in treatment of cancer |
| 08/08/2013 | WO2013116786A1 Cdk8/cdk19 selective inhibitors and their use in anti-metastatic and chemopreventative methods for cancer |
| 08/08/2013 | WO2013116765A1 Ribonucleotide reductase inhibitors and methods of use |
| 08/08/2013 | WO2013116656A1 Immunostimulatory compositions, particles, and uses related thereto |
| 08/08/2013 | WO2013116590A1 Inhibition of pattern recognition receptors in pancreatic cancer treatment using tlr inhibitors |
| 08/08/2013 | WO2013116541A1 Gamma interferon treated pluripotent germ layer origin antigen presenting cancer vaccine |
| 08/08/2013 | WO2013116505A1 Pluripotent germ layer origin antigen presenting cancer vaccine |
| 08/08/2013 | WO2013116382A1 Purinone compounds as kinase inhibitors |
| 08/08/2013 | WO2013116293A1 Combination of a rtk inhibitor with an anti - estrogen and use thereof for the treatment of cancer |
| 08/08/2013 | WO2013116291A1 Imidazo [4, 5 - b] pyridine derivatives as alk and jak modulators for the treatment of proliferative disorders |
| 08/08/2013 | WO2013116281A1 Combination therapy including isophosphoramide mustard, analogs, or salts thereof |
| 08/08/2013 | WO2013116228A1 Compounds and methods for inhibition of ap endonuclease-1/ redox factor-1 (hape1) activity |
| 08/08/2013 | WO2013116096A1 Methods for determining aggressiveness of a cancer and treatment thereof |
| 08/08/2013 | WO2013115965A1 Polymer-agent conjugates, particles, compositions, and related methods of use |
| 08/08/2013 | WO2013115926A2 Aspartyl-trna synthetase-fc conjugates |
| 08/08/2013 | WO2013114180A1 Cyclic peptide integrin derivatives for use as anticancer agents |
| 08/08/2013 | WO2013114113A1 1h-pyrrolo[2,3-b] pyridine derivatives and their use as kinase inhibitors |
| 08/08/2013 | WO2013113765A1 Hydroxyalkyl starch for the treatment of head and neck cancers by reduction of tumor growth rates |
| 08/08/2013 | WO2013113747A1 Hydroxyalkyl starch for the treatment of cancers by reduction of tumor growth rates |
| 08/08/2013 | WO2013113722A1 Anti-invasive compounds |
| 08/08/2013 | WO2013113669A1 Isoquinoline and naphthyridine derivatives |
| 08/08/2013 | WO2013113502A1 Negatively charged nucleic acid comprising complexes for immunostimulation |
| 08/08/2013 | WO2013113501A1 Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or pepide antigen |
| 08/08/2013 | WO2013113496A1 Hydroxyalkyl starch in combination with cytostatica for the treatment of cancers by reduction of tumor growth rates |
| 08/08/2013 | WO2013113326A1 Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen |
| 08/08/2013 | WO2013113325A1 Negatively charged nucleic acid comprising complexes for immunostimulation |
| 08/08/2013 | WO2013113097A1 Cyclic molecules as bruton's tyrosine kinase inhibitors |
| 08/08/2013 | WO2013078377A9 Anti-cd98 antibodies and methods of use thereof |